|
|
|
Volumn 305, Issue 5688, 2004, Pages 1222-1223
|
|
Cancer sharpshooters rely on DNA tests for a better aim
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
ANTINEOPLASTIC AGENT;
QUINAZOLINE DERIVATIVE;
CANCER CENTER;
FOOD AND DRUG ADMINISTRATION;
GENE MUTATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
NOTE;
PRIORITY JOURNAL;
PROTEIN TARGETING;
UNITED STATES;
ARTICLE;
CLINICAL TRIAL;
DIAGNOSTIC PROCEDURE;
GENETIC SCREENING;
GENETICS;
LUNG TUMOR;
METHODOLOGY;
MUTATION;
PHARMACOGENETICS;
CICADELLIDAE;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
GENETIC SCREENING;
HUMANS;
LUNG NEOPLASMS;
MOLECULAR DIAGNOSTIC TECHNIQUES;
MUTATION;
PHARMACOGENETICS;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 4344598294
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|